Press Release
Select category
  • Select category
  • Aerospace & Defense
    • Aircraft Components
    • Aircraft Material
    • Aviation
    • Defense
    • Marine
    • Security
    • Space
    • Technology
  • Agriculture
    • Materials
    • Technology
  • Automotive
    • Automotive Systems
    • Chemical Automotive
    • Component
    • Freight & Logistics
    • Material
    • Technology
    • Transport Mode
    • Utility
    • Vehicle
  • Automotive (CI)
  • Baby Products and supplies
  • BFSI
    • Banking
  • Chemical and Materials
    • Advanced Materials
    • Chemical
    • Coatings and Additives
    • Composites
    • Paints
    • Textile
  • Chemical and Materials (CI)
  • Construction & Manufacturing
    • Agriculture
    • Construction and Improvements
    • Construction Materials
    • Decor
    • Equipment and Machinery
    • Industrial Equipment & Automation
    • Packaging
  • Construction & Manufacturing (CI)
  • Consumer & Goods
    • Baby products and supplies
    • Beauty & Personal Care
    • Consumer
    • Home Products
    • Retail
    • Sports & Fitness
    • Travel
  • Electronics and Semiconductor
    • Communication Equipment
    • Display Technology
    • Electronic Component
    • Electronic Devices
    • Emerging Technologies
    • Security
    • Semiconductor
    • Sensor & Control
    • Technology
  • Electronics and Semiconductor (CI)
  • Energy and Power
    • Conventional Energy
    • Equipment
    • Power
    • Renewable Energy
    • Services
    • Storage and Distribution
    • Technology
    • Utility
  • Energy and Power (CI)
  • Food & Beverage
    • Baby Food
    • Beverages
    • Dairy Products
    • Food Ingredient
    • Food Products
    • Food Services and Hospitality
    • Packaging
    • Processed Food
  • Healthcare
  • Healthcare (CI)
  • Industrial Automation & Equipment
    • Component
  • Information and Communication Technology
    • Communication
    • Data Center
    • Data Center and Networking
    • Emerging Technologies
    • Entertainment Technologies
    • Security
    • Software and Services
    • Technology
  • Information and Communication Technology ICT (CI)
  • Life Science
    • Biotechnology
    • Diagnostics and Biotech
    • Healthcare Equipment
    • Healthcare IT
    • Medical Devices
    • Packaging
    • Pharmaceutical
    • Therapeutic
  • Miscellaneous
    • BFSI
    • Education and Training
  • Uncategorized
Evolve Business Intelligence Evolve Business Intelligence
  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
Menu
Evolve Business Intelligence Evolve Business Intelligence
Press Release
Life Science
Click to enlarge
Home » Our Report Repository » Pharmacogenomics Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis
Life Science
MHealth Applications Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis $ 3,475.00
Back to products
Life Science
Sports Medicine Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis $ 3,475.00

Pharmacogenomics Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

$ 3,475.00

Pharmacogenomics Market Research Report: Information By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Others), By Application (Cardiovascular Disease, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Others), By End User (Hospitals And Clinics, Research Institutions, Academic Institutes), and By Region — Forecast till 2033

Categories: Healthcare, Healthcare (CI), Life Science
Share:
  • Description
  • Table of Content
  • Connect To Analyst
  • Research Methodology
Description

Global Pharmacogenomics Market Size is expected to reach USD 15.70 Billion by 2033. The global Pharmacogenomics market size accounted for USD 8.35 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 8.66% from 2023 to 2033. Pharmacogenomics is a field of study that examines how a person’s genetic makeup influences their response to drugs. It combines pharmacology, which is the study of how drugs work in the body, with genomics, which is the study of an individual’s genes and their function. Pharmacogenomics seeks to understand how genetic variations can affect how a person metabolizes, responds to, and experiences the effects of medications. Pharmacogenomics takes into account an individual’s genetic information, such as their DNA sequence, genetic mutations, and gene expression patterns, to optimize drug therapy. It involves identifying genetic markers that are associated with drug response and using this information to guide drug selection, dosage adjustments, and treatment plans tailored to an individual’s genetic profile. By considering a person’s genetic makeup, pharmacogenomics aims to improve the safety and effectiveness of drug therapies, reduce adverse drug reactions, minimize trial-and-error approaches in drug prescribing, and ultimately achieve more personalized and precise medical care. Pharmacogenomics has applications in various areas of medicine, including oncology, psychiatry, cardiology, infectious diseases, and many other therapeutic areas. It is an interdisciplinary field that involves collaborations between researchers, clinicians, pharmacists, and other healthcare professionals, and the integration of genomic data into clinical decision-making processes. Pharmacogenomics holds the promise of advancing personalized medicine and transforming the way drugs are prescribed, administered, and monitored to optimize patient outcomes.

COVID-19 Impact Analysis

The COVID-19 pandemic had a mixed impact on the Pharmacogenomics market. While there has been increased focus on personalized medicine and remote healthcare services, disruptions in the supply chain, shifts in research focus, and impacts on clinical trials have also posed challenges for the industry. However, the long-term effects of the pandemic on the Pharmacogenomics market are still evolving, and the industry is likely to continue to adapt and innovate in response to the changing landscape.

Pharmacogenomics Market Dynamics

The major factors that have impacted the growth of Pharmacogenomics are as follows:

Drivers:

Increasing Demand for Precision Medicine

Precision medicine, which aims to deliver the right treatment to the right patient at the right time, has gained momentum in healthcare. Pharmacogenomics is a key component of precision medicine, as it enables healthcare providers to optimize drug selection and dosing based on an individual’s genetic profile, leading to more effective and safer treatments.

Growing Awareness of Adverse Drug Reactions

Adverse drug reactions (ADRs) are a significant burden on healthcare systems, leading to increased healthcare costs and patient morbidity and mortality. Pharmacogenomics can help identify genetic factors that predispose individuals to ADRs, allowing for proactive measures to mitigate the risk. As awareness of ADRs and the importance of personalized medicine grows, the demand for pharmacogenomics testing is expected to increase.

Restraint:

  • Limited Clinical Evidence

Despite the growing body of research supporting the role of pharmacogenomics in guiding drug therapy, there is still limited clinical evidence demonstrating the cost-effectiveness and clinical utility of pharmacogenomics testing in routine clinical practice. The lack of robust evidence may hinder the widespread adoption of pharmacogenomics in some healthcare settings, as clinicians and payers may require more data to support its clinical and economic value.

Opportunity:

Growing Demand for Precision Medicine

Precision medicine, which involves the use of genetic information to guide medical decisions, is gaining traction globally. Pharmacogenomics is a key component of precision medicine, as it provides valuable genetic information that can guide drug selection, dosing, and monitoring. The increasing demand for precision medicine, driven by advancements in genetic testing technologies, growing awareness among healthcare providers and patients, and the need for more targeted and effective therapies, presents a significant opportunity for the pharmacogenomics market.

Pharmacogenomics Segment Overview

By Technology

Based on the Technology, the market is segmented based on Next Generation Sequencing, Polymerase Chain Reaction, Gel electrophoresis, Mass Spectrometry, Microarray, and Others. During the projection period, the Next Generation Sequencing segment is expected to hold the largest market share. Next Generation Sequencing (NGS) is a powerful and widely used technology for analyzing genetic data, and it has revolutionized the field of Pharmacogenomics by enabling high-throughput sequencing of genes and other genomic regions to identify genetic variations that may influence drug response. The ability of NGS to provide comprehensive and high-resolution genetic information has made it a preferred method for Pharmacogenomics research and clinical applications.

By Application

Based on Application, the market has been divided into Cardiovascular Disease, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, and Others. The Cardiovascular Disease segment is expected to hold the largest market share. Cardiovascular Diseases (CVD) such as heart disease and stroke, are major global health concerns and a leading cause of morbidity and mortality worldwide. Pharmacogenomics has emerged as a promising approach for optimizing the management and treatment of CVDs by considering an individual’s genetic makeup in drug selection, dosing, and monitoring.

By End User

Based on End Users, the market has been divided into Hospitals and clinics, Research institutions, and Academic institutes. The Hospitals and clinics segment is expected to hold the largest market share. Hospitals and clinics are key settings where Pharmacogenomics can be applied in patient care. Many hospitals and clinics have started incorporating Pharmacogenomics testing into their clinical practice to aid in personalized medication management, optimize drug therapies, and minimize adverse drug reactions. Pharmacogenomics can be particularly relevant in specialty clinics, such as oncology or cardiology, where genetic testing can help guide treatment decisions and improve patient outcomes.

Global Pharmacogenomics Market Share, by Segmentation

Global Pharmacogenomics Market Regional Analysis

Based on region, the global pharmacogenomics market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to dominate the use of the market followed by the Asia-Pacific and Europe regions.

North America Market

North America is projected to dominate the pharmacogenomics market. The market for pharmacogenomics is influenced by various factors such as advancements in genomic research, increasing awareness about personalized medicine, and growing demand for precision therapies. North America has traditionally been a key player in the pharmaceutical and biotechnology industries and has a strong presence in the field of pharmacogenomics. The region has a well-established healthcare infrastructure, advanced research and development capabilities, and significant investments in genomics research. Additionally, the FDA (U.S. Food and Drug Administration) has been supportive of pharmacogenomics research and has provided regulatory guidance in this area, which has contributed to the growth of the pharmacogenomics market in North America.

Asia-Pacific Market

The Asia-Pacific region is projected to be a prominent growth market for Pharmacogenomics in the coming years. The Asia-Pacific region is known for its diverse population, which includes different ethnicities and genetic backgrounds. This genetic diversity can impact how individuals respond to drugs, making pharmacogenomics an important field for optimizing drug therapy in this region. As healthcare systems in the region continue to evolve and focus on precision medicine, the demand for pharmacogenomics is expected to increase. The Asia-Pacific region has seen significant advancements in genomics research in recent years, including large-scale genomic initiatives, research collaborations, and investments in genomic research infrastructure. These advancements are driving the development of pharmacogenomics research and applications in the region.

Competitive Landscape

The market comprises tier-1, tier-2, and local players. With their wide product portfolios, tier-1 and tier-2 players have a global reach. Since their strategic innovations and broad regional presence, companies such as Abbott Laboratories, Admera Health, Dynamic DNA Laboratories, Empire Genomics, and F. Hoffmann-La Roche Ltd lead the global Pharmacogenomics business. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as growth, product releases, and alliances.

Prominent Players:

  • Abbott Laboratories
  • Admera Health
  • Dynamic DNA Laboratories
  • Empire Genomics
  • Hoffmann-La Roche Ltd
  • Illumina Inc
  • OneOme
  • Myriad Genetics Inc
  • OPKO Health Inc
  • Invitae
  • Thermo Fisher Scientific Inc

Key Development:

May 2022: Invitae announced the release of the enhanced Invitae Pharmacogenomics (PGx) Panel, which provides access to a clinical decision support tool and the specialized Invitae Pharmacogenomics Mental Health Panel (CDST).

March 2022: Day-Lewis announced their intention to open a community pharmacy with a private pharmacogenomic testing service.

Scope of the Report

Global Pharmacogenomics Market, by Technology

  • Next Generation Sequencing
  • Polymerase Chain Reaction
  • Gel electrophoresis
  • Mass Spectrometry
  • Microarray
  • Others

Global Pharmacogenomics Market, by Application

  • Cardiovascular disease
  • Infectious diseases
  • Oncology
  • Neurological diseases
  • Psychiatry
  • Others

Global Pharmacogenomics Market, by End User

  • Hospitals and clinics
  • Research institutions
  • Academic institutes

Global Pharmacogenomics Market, by Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Benelux
    • Nordic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Indonesia
    • Austalia
    • Malaysia
    • India
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • South Africa
    • Rest of Middle East & Africa

 

Parameters Indicators
Market Size 2033: $15.70 Billion
CAGR 8.66% CAGR (2023-2033)
Base year 2022
Forecast Period 2023-2033
Historical Data 2021
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations Technology, Application, End User
Geographies Covered North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors Abbott Laboratories, Admera Health, Dynamic DNA Laboratories, Empire Genomics, F. Hoffmann-La Roche Ltd, Illumina Inc, OneOme, Myriad Genetics Inc, OPKO Health Inc, Thermo Fisher Scientific Inc.
Key Market Opportunities Growing Demand for Precision Medicine
Key Market Drivers Increasing Demand for Precision Medicine
Growing Awareness of Adverse Drug Reactions

 

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future Pharmacogenomics market trends and opportunities
  • Detailed analysis of current market drivers, restraining factors, and opportunities in the future
  • Pharmacogenomics market historical market size for the year 2021, and forecast from 2023 to 2033
  • Pharmacogenomics market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
  • To identify and understand the various factors involved in the global Pharmacogenomics market affected by the pandemic
  • To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company’s past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

For more details mail us at

[email protected]

Ask a question / additional requirement

Press Release

  • The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    August 26, 2023

  • The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    August 26, 2023

  • The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    August 26, 2023

  • The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    August 26, 2023

  • The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    August 26, 2023

  • The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    August 26, 2023

  • The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    August 26, 2023

  • The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    August 26, 2023

  • The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    August 26, 2023

  • The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    August 26, 2023

Frequently Asked Questions (FAQ)

  1. What is the study period of this market?
  • The study period of the global Pharmacogenomics market is 2022- 2033
  1. What is the growth rate of the global Pharmacogenomics market?
  • The global Pharmacogenomics market is growing at a CAGR of ~ 66% over the next 10 years
  1. Which region has the highest growth rate in the market of Pharmacogenomics?
  • Asia Pacific is expected to register the highest CAGR during 2023-2033
  1. Which region has the largest share of the global Pharmacogenomics market?
  • North America holds the largest share in 2022
  1. Who are the key players in the global Pharmacogenomics market?
  • Abbott Laboratories, Admera Health, Dynamic DNA Laboratories, Empire Genomics, F. Hoffmann-La Roche Ltd, Illumina Inc, OneOme, Myriad Genetics Inc, OPKO Health Inc, and Thermo Fisher Scientific Inc are the major companies operating in the market.
  1. Do you offer Post Sale Support?
  • Yes, we offer 16 hours of analyst support to solve the queries
  1. Do you sell particular sections of a report?
  • Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.
Table of Content

Table of Content

Chapter 1.   Executive Summary

Chapter 2.   Scope Of The Study

                     2.1.   Market Definition

                     2.2.   Scope Of The Study

                               2.2.1.   Objectives of Report

                               2.2.2.   Limitations

                     2.3.   Market Structure

Chapter 3.   Evolve BI Methodology

Chapter 4.   Market Insights and Trends

                     4.1.   Supply/ Value Chain Analysis

                               4.1.1.   Raw Application Providers

                               4.1.2.   Manufacturing Process

                               4.1.3.   Distributors/Retailers

                               4.1.4.   End-Use Industry

                     4.2.   Porter’s Five Forces Analysis

                               4.2.1.   Threat Of New Entrants

                               4.2.2.   Bargaining Power Of Buyers

                               4.2.3.   Bargaining Power Of Suppliers

                               4.2.4.   Threat Of Substitutes

                               4.2.5.   Industry Rivalry

                     4.3.   Impact Of COVID-19 on the Pharmacogenomics Market

                               4.3.1.   Impact on Market Size

                               4.3.2.   End-Use Industry Trend, Preferences, and Budget Impact

                               4.3.3.   Regulatory Framework/Government Policies

                               4.3.4.   Key Players' Strategy to Tackle Negative Impact

                               4.3.5.   Opportunity Window

                     4.4.   Technology Overview

                     4.5.   Macro factor

                     4.6.   Micro Factor

                        4.7.   Demand Supply Gap Analysis of the Pharmacogenomics Market

                        4.8.   Import Analysis of the Pharmacogenomics Market

                        4.9.   Export Analysis of the Pharmacogenomics Market

Chapter 5.   Market Dynamics

                     5.1.   Introduction

                     5.2.   DROC Analysis

                               5.2.1.   Drivers

                               5.2.2.   Restraints

                               5.2.3.   Opportunities

                               5.2.4.   Challenges

                     5.3.   Patent Analysis

                     5.4.   Industry Roadmap

                     5.5.   Parent/Peer Market Analysis

Chapter 6.   Global Pharmacogenomics Market, By Technology

                     6.1.   Introduction

                     6.2. Next-Generation Sequencing

                     6.3.   Polymerase Chain Reaction

                     6.4.   Gel electrophoresis

                     6.5.   Mass Spectrometry

                     6.6.   Microarray

                     6.7.   Others

Chapter 7.   Global Pharmacogenomics Market, By Application

                     7.1.   Introduction

                     7.2.   Cardiovascular disease

                     7.3.   Infectious diseases

                     7.4.   Oncology

                     7.5.   Neurological diseases

                     7.6.   Psychiatry

                     7.7.   Others

Chapter 8.   Global Pharmacogenomics Market, By End User

                     8.1.   Introduction

                     8.2.   Hospitals and clinics

                     8.3.   Research institutions

                     8.4.   Academic institutes

Chapter 9.   Global Pharmacogenomics Market, By Region

                     9.1.   Introduction

                     9.2.   North America

                               9.2.1.   Introduction

                               9.2.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               9.2.3.   Market Size and Forecast, By Country, 2023-2033

                               9.2.4.   Market Size and Forecast, By Technology, 2023-2033

                               9.2.5.   Market Size and Forecast, By Application, 2023-2033

                               9.2.6.   Market Size and Forecast, By End User, 2023-2033

                               9.2.7.   US

                                              9.2.7.1.   Introduction

                                              9.2.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.2.7.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.2.7.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.2.7.5.   Market Size and Forecast, By End User, 2023-2033

                               9.2.8.   Canada

                                              9.2.8.1.   Introduction

                                              9.2.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.2.8.4.   Market Size and Forecast, By Technology, 2023-2033

                                              9.2.8.5.   Market Size and Forecast, By Application, 2023-2033

                                              9.2.8.6.   Market Size and Forecast, By End User, 2023-2033

                     9.3.   Europe

                               9.3.1.   Introduction

                               9.3.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               9.3.3.   Market Size and Forecast, By Country, 2023-2033

                               9.3.4.   Market Size and Forecast, By Technology, 2023-2033

                               9.3.5.   Market Size and Forecast, By Application, 2023-2033

                               9.3.6.   Market Size and Forecast, By End User, 2023-2033

                               9.3.7.   Germany

                                              9.3.7.1.   Introduction

                                              9.3.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.3.7.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.3.7.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.3.7.5.   Market Size and Forecast, By End User, 2023-2033

                               9.3.8.   France

                                              9.3.8.1.   Introduction

                                              9.3.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.3.8.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.3.8.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.3.8.5.   Market Size and Forecast, By End User, 2023-2033

                               9.3.9.   UK

                                              9.3.9.1.   Introduction

                                              9.3.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.3.9.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.3.9.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.3.9.5.   Market Size and Forecast, By End User, 2023-2033

                               9.3.10.   Italy

                                              9.3.10.1.   Introduction

                                              9.3.10.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.3.10.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.3.10.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.3.10.5.   Market Size and Forecast, By End User, 2023-2033

                               9.3.11.   Rest Of Europe

                                              9.3.11.1.   Introduction

                                              9.3.11.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.3.11.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.3.11.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.3.11.5.   Market Size and Forecast, By End User, 2023-2033

                     9.4.   Asia-Pacific

                               9.4.1.   Introduction

                               9.4.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               9.4.3.   Market Size and Forecast, By Country, 2023-2033

                               9.4.4.   Market Size and Forecast, By Technology, 2023-2033

                               9.4.5.   Market Size and Forecast, By Application, 2023-2033

                               9.4.7.   Market Size and Forecast, By End User, 2023-2033

                               9.4.8.   China

                                              9.4.8.1.   Introduction

                                              9.4.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.4.8.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.4.8.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.4.8.5.   Market Size and Forecast, By End User, 2023-2033

                               9.4.9.   India

                                              9.4.9.1.   Introduction

                                              9.4.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.4.9.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.4.9.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.4.9.5.   Market Size and Forecast, By End User, 2023-2033

                               9.4.10.   Japan

                                              9.4.10.1.   Introduction

                                              9.4.10.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.4.10.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.4.10.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.4.10.5.   Market Size and Forecast, By End User, 2023-2033

                               9.4.11.   South Korea

                                              9.4.11.1.   Introduction

                                              9.4.11.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.4.11.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.4.11.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.4.11.5.   Market Size and Forecast, By End User, 2023-2033

                               9.4.12.   Rest Of Asia-Pacific

                                              9.4.11.1.   Introduction

                                              9.4.12.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.4.12.3.   Market Size and Forecast, By Technology, 2023-2033

                                              9.4.12.4.   Market Size and Forecast, By Application, 2023-2033

                                              9.4.12.5.   Market Size and Forecast, By End User, 2023-2033

                     9.5.   Rest Of The World (RoW)

                               9.5.1.   Introduction

                               9.5.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               9.5.3.   Market Size and Forecast, By Technology, 2023-2033

                               9.5.4.   Market Size and Forecast, By Application, 2023-2033

                               9.5.5.   Market Size and Forecast, By End User, 2023-2033

Chapter 10.   Company Landscape

                     10.1.   Introduction

                     10.2.   Vendor Share Analysis

                     10.3.   Key Development Analysis

                     10.4.   Competitor Dashboard

Chapter 11.   Company Profiles

                     11.1.   Abbott Laboratories

                               11.1.1.   Business Overview

                               11.1.2.   Financial Analysis

                                              11.1.2.1.   Financial – Existing/Funding

                               11.1.3.   Product Portfolio

                               11.1.4.   Recent Development and Strategies Adopted

                               11.1.5.   SWOT Analysis

                     11.2.   Admera Health

                               11.2.1.   Business Overview

                               11.2.2.   Financial Analysis

                                              11.2.2.1.   Financial – Existing/Funding

                               11.2.3.   Product Portfolio

                               11.2.4.   Recent Development and Strategies Adopted

                               11.2.5.   SWOT Analysis

                     11.3.   Dynamic DNA Laboratories

                               11.3.1.   Business Overview

                               11.3.2.   Financial Analysis

                                              11.3.2.1.   Financial – Existing/Funding

                               11.3.3.   Product Portfolio

                               11.3.4.   Recent Development and Strategies Adopted

                               11.3.5.   SWOT Analysis

                     11.4.   Empire Genomics

                               11.4.1.   Business Overview

                               11.4.2.   Financial Analysis

                                              11.4.2.1.   Financial – Existing/Funding

                               11.4.3.   Product Portfolio

                               11.4.4.   Recent Development and Strategies Adopted

                               11.4.5.   SWOT Analysis

                     11.5.   F. Hoffmann-La Roche Ltd

                               11.5.1.   Business Overview

                               11.5.2.   Financial Analysis

                                              11.5.2.1.   Financial – Existing/Funding

                               11.5.3.   Product Portfolio

                               11.5.4.   Recent Development and Strategies Adopted

                               11.5.5.   SWOT Analysis

                     11.6.   Illumina Inc

                               11.6.1.   Business Overview

                               11.6.2.   Financial Analysis

                                              11.6.2.1.   Financial – Existing/Funding

                               11.6.3.   Product Portfolio

                               11.6.4.   Recent Development and Strategies Adopted

                               11.6.5.   SWOT Analysis

                     11.7.   OneOme

                               11.7.1.   Business Overview

                               11.7.2.   Financial Analysis

                                              11.7.2.1.   Financial – Existing/Funding

                               11.7.3.   Product Portfolio

                               11.7.4.   Recent Development and Strategies Adopted

                               11.7.5.   SWOT Analysis

                     11.8 Myriad Genetics Inc

                               11.8.1.   Business Overview

                               11.8.2.   Financial Analysis

                                              11.8.2.1.   Financial – Existing/Funding

                               11.8.3.   Product Portfolio

                               11.8.4.   Recent Development and Strategies Adopted

                               11.8.5.   SWOT Analysis

                     11.9.   OPKO Health Inc

                               11.9.1.   Business Overview

                               11.9.2.   Financial Analysis

                                              11.9.2.1.   Financial – Existing/Funding

                               11.9.3.   Product Portfolio

                               11.9.4.   Recent Development and Strategies Adopted

                               11.9.5.   SWOT Analysis

                     11.10.   Thermo Fisher Scientific Inc

                               11.10.1.   Business Overview

                               11.10.2.   Financial Analysis

                                              11.10.2.1.   Financial – Existing/Funding

                               11.10.3.   Product Portfolio

                               11.9.4.   Recent Development and Strategies Adopted

                               11.9.5.   SWOT Analysis

Chapter 12.   Key Takeaways

 

Connect To Analyst

Connect To Analyst

Research Methodology

Research Methodology

Related products

Life Science

Gene Therapy Cell Culture Media Market Analysis and Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00

Gene Therapy Cell Culture Media Market By Product Type (Media, Viral Vectors), By Application (Biotechnology & Pharmaceutical Industry, Research Laboratory, Academic Institute, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_333| Page: 164 | Published Date: May 2021
Add to cart
Quick view
Life Science

Inhaled Nitric Oxide Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00
Inhaled Nitric Oxide Market By Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Diseases, Acute Respiratory Distress Syndrome, Others), By Type (Delivery Systems, Gas) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_330| Page: 161 | Published Date: March 2021
Add to cart
Quick view
Life Science

Proteomics Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00
Proteomics Market By Component (Instruments, Reagents, Services,), By Application (Drug Discovery, Diseases Diagnosis) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_331 | Page: 162 | Published Date: March 2021
Add to cart
Quick view
Life Science

Track and Trace Solutions Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00
Track and Trace Solutions Market By Product Type (Hardware Components, Software, Standalone Platforms, Tracking, Tracing and Reporting Solutions), By Application (Serialization Solutions, Medical Devices Serialization Aggregation Solution) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_332| Page: 163| Published Date: March 2021
Add to cart
Quick view
Healthcare

Global Telehealth Market

$ 3,475.00
Telehealth Market By Component (Hardware, Software, Service) By Delivery Mode (Web-based, Cloud-based, On-Premise) By End User (Provider, Payer, Patient, Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2027
Add to cart
Quick view
Healthcare

Global Healthcare Blockchain Technology Market

$ 3,475.00
Healthcare Blockchain Technology Market By Type (Public and Private) By Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing, Supply Chain Management, and Others) By End Use (Hospitals, Healthcare Payers, Healthcare Providers, Pharmaceutical Companies, and Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2026
Add to cart
Quick view
Life Science

Particle Counters Market Analysis and Global Forecast (2020-2028) with COVID Impact Analysis

$ 3,475.00
Particle Counters Market By Product Type (Cleanroom Monitoring, Drinking Water Contamination Monitoring, Aerosol Monitoring and Research, Others), By Type (Airborne Particle Counters, Liquid Particle Counters) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_338| Page: 169 | Published Date : March 2021
Add to cart
Quick view
Healthcare

Global Gene Therapy Market

$ 3,475.00
Gene Therapy Market By Therapy Type (Somatic, Germline) By Vector Type (Non-Viral Vectors, Viral Vectors) By Application (Cancer Diseases, Monogenic Diseases, Infectious Diseases, Cardiovascular Diseases, Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2027
Add to cart
Quick view

Uncover Market Secrets: Get Market Insights in Your Inbox 🚀

Join over 5,000 professionals staying ahead of industry trends. Subscribe to our weekly market research newsletter.

Join our community of industry leaders and stay ahead of the curve. Subscribe now for data-driven market intelligence and strategic recommendations that will set your business on a path to success! Don't miss out on our FREE exclusive insights – sign up today and soar above your competition!🚀

cropped-evolvebi-Logo-2021-1.png
M/S Evolve Business Intelligence C-218, 2nd floor, M-Cube, N.H. – 48, Balitha, Vapi, Valsad- Gujarat
Email: [email protected]

Email: [email protected]

  • Important Links
    • About Evolvebi
    • Competitive Intelligence
    • Become a reseller
    • Contact Us
  • Top Search By Countries Hot
    • United State
    • Europe
    • Asia Pacific
    • Middle East & Africa
    • Latin America

© 2021 - 2023 Evolve Business Intelligence. All rights reserved. Developed by Nectron

Privacy Policy | Terms and Conditions | Cancellation and Refund policy

  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
More info Accept
I allow the Site owner to contact me via email/phone to discuss this enquiry. (If you want to know more about the way this site handles the data, then please go through our privacy policy).
Brought to you by WisdmLabs: WordPress Development Experts

Sending...